Literature DB >> 6725553

Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis.

D M Small, M G Bond, D Waugh, M Prack, J K Sawyer.   

Abstract

To identify the temporal changes occurring during progression and regression of atherosclerosis in nonhuman primates, we have studied the physicochemical and histological characteristics of arterial wall lesions during a 30-mo progression period of diet-induced hypercholesterolemia and during a 12-mo period of regression. Three groups of cynomolgous monkeys (Macaca fascicularis) were studied. Control groups were fed a basal chow diet for 18, 24, and 30 mo and were compared with progression groups that were fed a high-cholesterol-containing diet for up to 30 mo. Regression groups were fed a high-cholesterol diet for 18 mo to induce atherosclerosis and then fed monkey chow for up to 12 mo. The progression group monkeys were killed at 6, 12, 18, 24, and 30 mo, and the regression animals were killed at 24 and 30 mo (i.e., after 6 and 12 mo of being fed a noncholesterol-containing chow diet). Histology and morphometry, physical microscopy for cholesterol monohydrate crystals, foam cell and droplet melting points and chemical composition studies were completed on a large number of individual arterial lesions. Control animals had very little cholesterol ester, rare foam cells, and no extracellular cholesterol ester droplets or cholesterol crystals. During progression, the arteries first increased cholesterol ester content to produce high melting (approximately 45 degrees C) foam cell-rich lesions essentially devoid of cholesterol crystals. With time, the number of cholesterol crystals increased so that by 30 mo large numbers were present. Foam cells decreased with time but their melting temperature remained high while that of extracellular droplets fell to approximately 38 degrees C. Between 18 and 30 mo necrosis appeared and worsened. After 6-mo regression, unexpected changes occurred in the lesions. Compared with 24-mo progression, the chemical composition showed a relative increase in free cholesterol, a decrease in cholesterol ester and microscopy revealed large numbers of cholesterol crystals. Concomitantly, foam cells decreased and the melting temperature of both intra- and extracellular cholesterol ester markedly decreased. After 12-mo regression cholesterol decreased, cholesterol crystals and necrosis diminished and collagen appeared increased. Thus, during progression there is initially an increase in the number of foam cells containing very high-melting intracellular cholesterol ester droplets. By 30 mo, cholesterol crystals and necrosis dominate and high-melting foam cells appear only at lesion margins, suggesting that the initial process continues at the lesion edge. The lower melting point of extracellular esters indicates a lipid composition different from intracellular droplets. Thus, the changes observed in these animals generally reflect those predicted for progression of human atherosclerosis. During the initial 6 mo of regression, necrosis remains, the number of foam cell decreases, and cholesterol ester content decreases; however the relative proportion of free cholesterol content increases, and large numbers of cholesterol content are formed. Thus, large and rapid decreases in serum cholesterol concentration to produce regression in fact may result in the precipitation of cholesterol monohydrate and an apparent worsening of the lesions. More prolonged regression (12-mo) tends to return the lipid composition of the artery wall towards normal, partially reduces cholesterol crystals, and results in an improved but scarred intima.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725553      PMCID: PMC437070          DOI: 10.1172/JCI111366

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Receptor-mediated control of cholesterol metabolism.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1976-01-16       Impact factor: 47.728

2.  The gross and histologic appearance and the lipid composition of normal intima and lesions from human coronary arteries and aorta.

Authors:  R V Panganamala; J C Geer; H M Sharma; D G Cornwell
Journal:  Atherosclerosis       Date:  1974 Jul-Aug       Impact factor: 5.162

3.  Physical-chemical basis of lipid deposition in atherosclerosis.

Authors:  D M Small; G G Shipley
Journal:  Science       Date:  1974-07-19       Impact factor: 47.728

4.  The microdissection of large atherosclerotic plaques to give morphologically and topographically defined fractions for analysis. 1. The lipids in the isolated fractions.

Authors:  E B Smith; R S Slater
Journal:  Atherosclerosis       Date:  1972 Jan-Feb       Impact factor: 5.162

5.  Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets.

Authors:  M L Armstrong; M B Megan
Journal:  Circ Res       Date:  1972-06       Impact factor: 17.367

6.  Significance of cholesterol esters as liquid crystal in human atherosclerosis.

Authors:  Y Hata; W Insull
Journal:  Jpn Circ J       Date:  1973-03

7.  A study of atherosclerosis regression in Macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl.

Authors:  T B Clarkson; M G Bond; B C Bullock; C A Marzetta
Journal:  Exp Mol Pathol       Date:  1981-06       Impact factor: 3.362

8.  Depletion of aortic free and ester cholesterol by dietary means in rhesus monkeys with fatty streaks.

Authors:  M G Kokatnur; G T Malcom; D A Eggen; J P Strong
Journal:  Atherosclerosis       Date:  1975 Mar-Apr       Impact factor: 5.162

9.  Lipid droplets in atherosclerotic fatty streaks of human aorta.

Authors:  P D Lang; W Insull
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

10.  The physicochemical basis of cholesterol gallstone formation in man.

Authors:  W H Admirand; D M Small
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

View more
  34 in total

Review 1.  Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.

Authors:  R A Archbold; A D Timmis
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

Review 2.  Quantitative evaluation of carotid atherosclerotic plaques by magnetic resonance imaging.

Authors:  Chun Yuan; Xue-Qiao Zhao; Thomas S Hatsukami
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 3.  Coronary arterial remodeling: from bench to bedside.

Authors:  Paul Schoenhagen; Steven E Nissen; E Murat Tuzcu
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

4.  Histological changes and risk factor associations in type 2 atherosclerotic lesions (fatty streaks) in young adults.

Authors:  Satoki Homma; Dana A Troxclair; Arthur W Zieske; Gray T Malcom; Jack P Strong
Journal:  Atherosclerosis       Date:  2011-07-21       Impact factor: 5.162

5.  Concentration-Dependent Diversifcation Effects of Free Cholesterol Loading on Macrophage Viability and Polarization.

Authors:  Xiaoyang Xu; Aolin Zhang; Ningjun Li; Pin-Lan Li; Fan Zhang
Journal:  Cell Physiol Biochem       Date:  2015-08-28

6.  Oral supplement of six selective amino acids arrest progression renal failure in uremic patients.

Authors:  Hippocrates Yatzidis
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

7.  Carotid thin fluttering bands: A new element of arterial wall remodelling? An ultrasound study.

Authors:  Luca Costanzo; Andrea Sole; Corrado Tamburino; Luigi Di Pino
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-16       Impact factor: 2.357

8.  Phase behavior and crystalline structures of cholesteryl ester mixtures: a C-13 MASNMR study.

Authors:  W Guo; J A Hamilton
Journal:  Biophys J       Date:  1995-06       Impact factor: 4.033

9.  Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice.

Authors:  Catherine Martel; Wenjun Li; Brian Fulp; Andrew M Platt; Emmanuel L Gautier; Marit Westerterp; Robert Bittman; Alan R Tall; Shu-Hsia Chen; Michael J Thomas; Daniel Kreisel; Melody A Swartz; Mary G Sorci-Thomas; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

Review 10.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.